Shares of Medline, a medical-supplies manufacturer and distributor, rose 41% in their trading debut Wednesday after the ...

A day that featured the biggest initial public offering in four years also saw the Nasdaq Composite close sharply lower. The tech-heavy index slid 1.8%. The S&P 500 dropped 1.1%. The Dow Jones ...

Today, Dec. 18, 2025, a bullish analyst call spotlights Rivian’s R2 roadmap, autonomy push, and evolving EV strategy.

Medical supply giant Medline's shares rose 41% above their offer price in their hotly anticipated debut, capping a strong year for new listings and fuelling optimism for 2026.

Medline shares surged in their trading debut Wednesday, after the medical supply company raised $6.26 billion in one of the ...

Rivian’s ($RIVN) upcoming R2 launch, set for mid-2026, could be a major breakthrough for the electric vehicle maker. The R2 ...

Discover why RIVN is a Buy: strong balance sheet, new SaaS revenue, and growth prospects position it well for long-term ...

Jim Boyle, Medline CEO, celebrates with others as medical supplies giant Medline (MDLN) holds it's IPO at Nasdaq stock market ...

Shares are getting a boost from Baird’s upgrade as well as new features and updates for its R1 SUVs. The update to the ...

Today’s Forbes Daily newsletter covers Trump’s economic address, YouTube takes the Oscars, latest on Warner Bros. deal, Tesla ...

Medline is majority owned by a private-equity partnership made up of funds managed by Blackstone, Carlyle, and Hellman & ...

A day that featured the biggest initial public offering in four years also saw the Nasdaq Composite close sharply lower. The tech-heavy index slid 1.8%. The S&P 500 dropped 1.1%. The Dow Jones ...